What is the ESG rating for LLY?

Eli Lilly and Company has the following ESG ratings: MSCI ESG Rating: a, Sustainalytics ESG Risk: 59, ESG Enterprise Score: BBB.

What are the main strengths of investing in LLY?

The main strengths of investing in Eli Lilly and Company include: Lilly has a history of being a socially responsible company, The company is committed to environmental sustainability, with a goal to reduce its greenhouse gas emissions by 25% by 2025, Lilly has a strong focus on diversity and inclusion, with programs in place to support employees from underrepresented groups.

What are the potential drawbacks of investing in LLY?

Potential drawbacks of investing in Eli Lilly and Company include: The company's share price is down 7% over the past year, The company is facing several lawsuits alleging that it failed to warn patients of the risks associated with its diabetes drug and dulaglutide.

What are the key financial metrics for LLY?

Key financial metrics for Eli Lilly and Company include: Market Cap: $67061.78 billion, Dividend Yield: 0.80%.

${quote.companyName} (${symbol}) Stock Analysis

Price Chart

Real-time data provided by Alpha Vantage

Financial Metrics

Market Cap

$265.0B

P/E Ratio

N/A

52-Week High

$315.00

52-Week Low

$215.00

Volume

9,014,757

Average Volume

N/A

Dividend Yield

250.00%

Beta

N/A

Key Statistics

Market Cap$265.0B

P/E Ratio (TTM)N/A

Volume9,014,757

Avg VolumeN/A

52-Week High$315.00

52-Week Low$215.00

Dividend Yield250.00%

BetaN/A

ESG Ratings

Overall ESG Score59.0/100

Environmental53.0/100

Social69.0/100

Governance59.0/100

LLY Inc.

LLY

$265.00

LLY Inc. (LLY)

Price Chart

Financial Metrics

Key Statistics

ESG Ratings